MedPath

A study to test how well different doses of BI 3034701 are tolerated by healthy men and people with overweight or obesity

Phase 1
Active, not recruiting
Conditions
Healthy volunteer trial
Registration Number
2023-508767-79-00
Lead Sponsor
Boehringer Ingelheim International GmbH, Boehringer Ingelheim International GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing, recruitment ended
Sex
Not specified
Target Recruitment
125
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Charite Research Organisation GmbH

🇩🇪

Berlin, Germany

Charite Research Organisation GmbH
🇩🇪Berlin, Germany
Christian Keicher
Site contact
+49030450539200
christian.keicher@charite-research.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.